American pharmaceutical company Pfiza, one of the world leaders in this industry, from January to September 2018, increased its net profit by 28% in annual terms to 11 billion 546 million dollars, finversia.ru writes, referring to the company's statements. Earnings per share rose to 1 dollar 92 cents from 1 dollar 49 cents a year earlier. Revenue increased by 2% and amounted to 39 billion 700 million dollars. In the third quarter, Pfiza net profit increased 1.5 times, and its revenue increased by 1%. At the same time, in the sector of basic medical goods and services a decrease by 4% was observed.
Samsung Electronics Co Ltd looks forward to the second half of the year as it expects a larger increase in chip demand brought by new smartphone launches. However, the company warned that the coronavirus crisis and trade disputes carry risks. Samsung, ...
China’s industrial firms had seen an increase in profits for two consecutive months. This came as the most rapid pace ever recorded in over a year, suggesting that the country’s recuperation from the novel coronavirus pandemic ...
Renault SA (RENA.PA) announced on Monday that its global car sales fell by 34.9% in the first half of the year due to the impact of the coronavirus pandemic. However, the company said that it had seen some signs of recovery in June. The French ...
American multinational automaker Ford Motor Co. (F.N) announced on Thursday that its vehicle sales increased by 3% from April to June in mainland China. It would be the first time that the company's first quarterly sales rose in the world's ...
The Bank of Japan (BOJ) on Wednesday offered ¥8.28 trillion ($77.74 billion) in loans to financial institutions under its first phase of its new lending program. The move came in a bid to transfer funds to firms that have been heavily ...